Optovue

Optovue Corporation, founded in 2003 in Fremont, California, is a pioneering ophthalmic device company that focuses on advancing ocular diagnostics through next-generation imaging technologies. The company has established partnerships with eye care professionals and clinical researchers to develop innovative imaging technologies aimed at improving the diagnosis and treatment of ocular diseases. Utilizing Fourier-Domain OCT technology, Optovue has created ultra-high speed, high-resolution FD-OCT devices that provide superior retinal diagnostic capabilities. This technology benefits patients with a range of conditions including macular degeneration, diabetic retinopathy, glaucoma, and other macular diseases. The latest investment in Optovue amounted to $30.00 million, which was secured through a Private Equity Round on 11 November 2015, with Delta Power Solutions as the investor. The company operates within the Health Care and Medical Devices industries, demonstrating a commitment to driving innovation and enhancing patient outcomes within the field of ocular care. Optovue's slogan, "Pioneering the future of ocular diagnostics," reflects its dedication to leveraging advanced imaging technologies to elevate eye care and improve patient outcomes.